A carregar...
Trastuzumab‐containing regimens for metastatic breast cancer
BACKGROUND: Patients with breast cancer are classified as having cells that over‐express the human epidermal growth factor receptor 2 (known as HER2‐positive) or not (HER2‐negative). Typically, patients with HER2‐positive disease have a worse prognosis. Trastuzumab is a selective treatment that targ...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2014
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464904/ https://ncbi.nlm.nih.gov/pubmed/24919460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006242.pub2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|